248
MULTIMODAL PREHABILITATION IS ASSOCIATED WITH IMPROVED SURGICAL OUTCOMES IN IBD
Date
May 18, 2024
Tracks
Related Products
INFLIXIMAB CLEARANCE IN RELATION TO DISEASE ACTIVITY DURING INDUCTION AND MAINTENANCE THERAPY OF ACUTE SEVERE AND AMBULATORY PEDIATRIC ULCERATIVE COLITIS
BACKGROUND: The low fermentable oligosaccharide, disaccharide, monosaccharide, and polyol (FODMAP) diet, which restricts FODMAP intake, currently is used as a treatment for pain-related disorders of gut-brain interaction (DGBI)…
RISANKIZUMAB MAINTENANCE THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: EFFICACY AND SAFETY IN THE RANDOMIZED PHASE 3 COMMAND STUDY
BACKGROUND: Risankizumab (RZB), a monoclonal antibody targeting interleukin-23 p19, was evaluated for maintenance therapy in patients with moderately to severely active ulcerative colitis (UC) and clinical response to RZB intravenous (IV) induction treatment in a phase 3 double-blind, placebo (PBO)…
A QUALITY-OF-CARE INITIATIVE TO IMPROVE URGENT CARE ACCESS IN AMBULATORY CLINICS IS ASSOCIATED WITH REDUCED INPATIENT COSTS IN INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE IBD QORUS URGENT CARE IMPROVEMENT INITIATIVE
BACKGROUND: IBD Qorus is a multicenter adult IBD learning health system which has worked to reduce unnecessary ED and hospital utilization via a recent urgent care improvement initiative. Building upon initial work by Almario et al…
Novel Observations in IBD
MONITORING IBD BY INTESTINAL ULTRASOUND DECREASES TIME TO TREATMENT CHANGE AND TIME TO REMISSION IN COMPARISON TO CONVENTIONAL MANAGEMENT: ANALYSIS OF PATIENTS WITH IBD ON MULTIPLE IBD THERAPIES